AstraZeneca says COVID-19 vaccine found 79 percent effective in US trial

AstraZeneca announced on Monday that its vaccine was 79 percent effective in preventing symptomatic COVID-19 in phase three U.S. testing with no safety concerns found.The company said in a statement that the vaccine, developed in…